Mon. 13 May 2024, 8:21am ET
Benzinga
Earnings, Earnings Beats, News
Compass Therapeutics (NASDAQ:CMPX) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.11) by 27.27 percent. This is a 33.33 percent decrease over losses of $(0.06) per share from the same period last year.